These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37759234)

  • 1. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
    Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
    World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
    Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
    PeerJ; 2022; 10():e14432. PubMed ID: 36518297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
    Wang Y; Liu T; Zhang K; Huang RH; Jiang L
    Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma.
    Zhai S; Li Y; Yang Y; Lang W; Liu X; Liu K; Qu J; Zhu L
    Front Immunol; 2024; 15():1361657. PubMed ID: 39108273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
    Zhou Y; Zhang Q; Gao G; Zhang X; Liu Y; Yuan S; Wang X; Chen JJ
    J Virol; 2016 Jul; 90(13):6071-6084. PubMed ID: 27099318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers.
    Dong X; Liu T; Li Z; Zhai Y
    Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
    Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
    Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
    Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
    Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker.
    Tang Y; Lei Y; Gao P; Jia J; Du H; Wang Q; Yan Z; Zhang C; Liang G; Wang Y; Ma W; Xing N; Cheng L; Ren L
    BMC Cancer; 2023 Apr; 23(1):328. PubMed ID: 37038185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
    Zhong H; Shi Q; Wen Q; Chen J; Li X; Ruan R; Zeng S; Dai X; Xiong J; Li L; Lei W; Deng J
    Front Immunol; 2023; 14():1058627. PubMed ID: 36923407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer.
    Yang K; Ma Y; Chen W; Liu L; Yang Z; He C; Zheng N; Liu X; Cheng X; Song J; Chen Y; Qiao H; Zhang R
    Sci Rep; 2024 Apr; 14(1):8575. PubMed ID: 38609450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer analysis of the oncogenic effects of G-protein-coupled receptor kinase-interacting protein-1 and validation on liver hepatocellular carcinoma.
    Wang T; Su K; Wang L; Shi Y; Niu Y; Zhou Y; Wang A; Wu T
    Adv Clin Exp Med; 2023 Oct; 32(10):1139-1147. PubMed ID: 36994687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.
    Jiang Y; Yu Z; Zheng H; Zhou X; Zhou M; Geng X; Zhu Y; Huang S; Gong Y; Guo L
    Aging (Albany NY); 2024 Jul; 16(13):10813-10831. PubMed ID: 38980253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-Cancer Analysis Based on
    Zhang Y; Wang S; Han S; Feng Y
    Front Oncol; 2022; 12():844794. PubMed ID: 35359375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.